Mellgren G, Vintermyr O K, Bøe R, Døskeland S O
Department of Anatomy, University of Bergen, Norway.
Exp Cell Res. 1993 Apr;205(2):293-301. doi: 10.1006/excr.1993.1089.
Primary rat hepatocytes exposed to the phosphoprotein phosphatase (PP) inhibitors microcystin-LR and okadaic acid showed extensive surface protrusions and release of cell fragments, like cells in apoptosis. Microinjected microcystin fully reproduced these effects; the calculated intracellular concentration required for 50% effect being about 1 microM. The effects were counteracted by antagonists of calmodulin or of the multifunctional calmodulin-activated protein kinase II. The DNA replication of the epidermal growth factor-stimulated hepatocytes was nearly completely inhibited by okadaic acid at concentrations below those giving overt morphological effects. However, microcystin did not inhibit the DNA replication. Calmodulin antagonists counteracted the effect of okadaic acid on DNA replication. Microinjection of inhibitor-1 and inhibitor-2 (both directed against PP1) had no effect on DNA replication. Based on the known selectivity of okadaic acid for PP type 2A versus that of type 1, and the lack of such selectivity for microcystin, it is concluded that DNA replication is abolished by moderate inhibition of PP2A. Inhibition of PP1 did not impede DNA replication, suggesting that the two major liver phosphatases may have opposite roles in the regulation of hepatocyte DNA replication.
暴露于磷蛋白磷酸酶(PP)抑制剂微囊藻毒素-LR和冈田酸的原代大鼠肝细胞表现出广泛的表面突起和细胞碎片释放,类似于凋亡细胞。显微注射微囊藻毒素可完全重现这些效应;产生50%效应所需的计算细胞内浓度约为1微摩尔。这些效应可被钙调蛋白或多功能钙调蛋白激活蛋白激酶II的拮抗剂抵消。在产生明显形态学效应的浓度以下,冈田酸几乎完全抑制了表皮生长因子刺激的肝细胞的DNA复制。然而,微囊藻毒素并未抑制DNA复制。钙调蛋白拮抗剂抵消了冈田酸对DNA复制的影响。显微注射抑制剂-1和抑制剂-2(均针对PP1)对DNA复制没有影响。基于已知的冈田酸对2A型PP与1型PP的选择性,以及微囊藻毒素缺乏这种选择性,得出结论:适度抑制PP2A可消除DNA复制。抑制PP1并不妨碍DNA复制,这表明两种主要的肝脏磷酸酶在肝细胞DNA复制的调节中可能具有相反的作用。